Hoenigl, Martin
Chaillon, Antoine
Morris, Sheldon R.
Little, Susan J.
Article History
Received: 15 February 2016
Accepted: 25 April 2016
First Online: 16 May 2016
Competing interests
: Dr. Hoenigl served on the speakers’ bureau of Merck. Dr. Little reported grant funding from Gilead Sciences, Inc. All other authors no conflicts.